Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. [electronic resource]
Producer: 20200417Description: 146-152 p. digitalISSN:- 1099-1069
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- therapeutic use
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Incidence
- Japan -- epidemiology
- Lymphoma, B-Cell -- pathology
- Lymphoproliferative Disorders -- epidemiology
- Male
- Middle Aged
- Prognosis
- Retrospective Studies
- Rituximab -- therapeutic use
- Survival Rate
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.